{"transactions":[{"id":3031512,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-09-15T18:04:24.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":474,"price":20,"value":9480.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.40, inclusive."}],"balance_after":585600,"source":{"system":"sec-edgar","filing":"0001179110-20-009785","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009785/edgar.xml","form_type":"4"}},{"id":3031511,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-09-15T18:04:24.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":2080,"price":19.26,"value":40060.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.67 to $19.50, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":586074,"source":{"system":"sec-edgar","filing":"0001179110-20-009785","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009785/edgar.xml","form_type":"4"}},{"id":3032420,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-14T16:37:53.000Z","date":"2020-09-10","kind":"sale","acquired":false,"shares":239,"price":18,"value":4302.0,"ownership":{"direct":true},"balance_after":588154,"source":{"system":"sec-edgar","filing":"0001179110-20-009717","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009717/edgar.xml","form_type":"4"}},{"id":3034499,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-10T15:58:08.000Z","date":"2020-09-09","kind":"sale","acquired":false,"shares":4913,"price":19.27,"value":94673.51,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.02 to $19.715, inclusive."}],"balance_after":588393,"source":{"system":"sec-edgar","filing":"0001179110-20-009662","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009662/edgar.xml","form_type":"4"}},{"id":3034498,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-10T15:58:08.000Z","date":"2020-09-09","kind":"sale","acquired":false,"shares":5309,"price":18.1,"value":96092.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.82, inclusive."}],"balance_after":593306,"source":{"system":"sec-edgar","filing":"0001179110-20-009662","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009662/edgar.xml","form_type":"4"}},{"id":3034497,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-10T15:58:08.000Z","date":"2020-09-08","kind":"sale","acquired":false,"shares":3108,"price":18.94,"value":58865.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $19.29, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4."}],"balance_after":598615,"source":{"system":"sec-edgar","filing":"0001179110-20-009662","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009662/edgar.xml","form_type":"4"}},{"id":3037866,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-04T16:39:05.000Z","date":"2020-09-03","kind":"sale","acquired":false,"shares":52,"price":20.19,"value":1049.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.02 to $20.20, inclusive."}],"balance_after":601723,"source":{"system":"sec-edgar","filing":"0001179110-20-009590","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009590/edgar.xml","form_type":"4"}},{"id":3037865,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-04T16:39:05.000Z","date":"2020-09-02","kind":"sale","acquired":false,"shares":207,"price":20.68,"value":4280.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.21 to $20.80, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":601775,"source":{"system":"sec-edgar","filing":"0001179110-20-009590","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009590/edgar.xml","form_type":"4"}},{"id":3042751,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-01T16:53:10.000Z","date":"2020-08-28","kind":"sale","acquired":false,"shares":771,"price":22.09,"value":17031.39,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.475, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":601982,"source":{"system":"sec-edgar","filing":"0001179110-20-009466","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009466/edgar.xml","form_type":"4"}},{"id":3044684,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-28T15:56:18.000Z","date":"2020-08-27","kind":"sale","acquired":false,"shares":616,"price":22.37,"value":13779.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.08 to $23.005, inclusive."}],"balance_after":602753,"source":{"system":"sec-edgar","filing":"0001179110-20-009407","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009407/edgar.xml","form_type":"4"}},{"id":3044683,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-28T15:56:18.000Z","date":"2020-08-26","kind":"sale","acquired":false,"shares":1418,"price":22.4,"value":31763.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.15 to $23.03, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":603369,"source":{"system":"sec-edgar","filing":"0001179110-20-009407","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009407/edgar.xml","form_type":"4"}},{"id":3046586,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-26T16:27:27.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":2461,"price":22.73,"value":55938.53,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.16 to $23.10, inclusive."}],"balance_after":604787,"source":{"system":"sec-edgar","filing":"0001179110-20-009359","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009359/edgar.xml","form_type":"4"}},{"id":3046585,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-26T16:27:27.000Z","date":"2020-08-24","kind":"sale","acquired":false,"shares":974,"price":23.16,"value":22557.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.09 to $23.29, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":607248,"source":{"system":"sec-edgar","filing":"0001179110-20-009359","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009359/edgar.xml","form_type":"4"}},{"id":3048898,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-24T09:51:14.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":510,"price":24.183,"value":12333.33,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.515, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) to this Form 4."}],"balance_after":608222,"source":{"system":"sec-edgar","filing":"0001179110-20-009241","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009241/edgar.xml","form_type":"4"}},{"id":3051258,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-20T16:18:56.000Z","date":"2020-08-18","kind":"sale","acquired":false,"shares":200,"price":25.19,"value":5038.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.11 to $25.28, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) to this Form 4."}],"balance_after":608732,"source":{"system":"sec-edgar","filing":"0001179110-20-009191","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009191/edgar.xml","form_type":"4"}},{"id":3054572,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-18T17:48:54.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":1548,"price":25.11,"value":38870.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.55, inclusive."}],"balance_after":608932,"source":{"system":"sec-edgar","filing":"0001179110-20-009153","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009153/edgar.xml","form_type":"4"}},{"id":3054571,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-18T17:48:54.000Z","date":"2020-08-14","kind":"sale","acquired":false,"shares":700,"price":25.09,"value":17563.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.32, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":610480,"source":{"system":"sec-edgar","filing":"0001179110-20-009153","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020009153/edgar.xml","form_type":"4"}},{"id":3072635,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-31T16:59:36.000Z","date":"2020-07-30","kind":"sale","acquired":false,"shares":1317,"price":26.14,"value":34426.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.525, inclusive."}],"balance_after":611180,"source":{"system":"sec-edgar","filing":"0001179110-20-008623","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008623/edgar.xml","form_type":"4"}},{"id":3072634,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-31T16:59:36.000Z","date":"2020-07-29","kind":"sale","acquired":false,"shares":100,"price":28.45,"value":2845.0,"ownership":{"direct":true},"balance_after":612497,"source":{"system":"sec-edgar","filing":"0001179110-20-008623","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008623/edgar.xml","form_type":"4"}},{"id":3072633,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-31T16:59:36.000Z","date":"2020-07-29","kind":"sale","acquired":false,"shares":600,"price":27.28,"value":16368.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.02 to $27.83, inclusive."}],"balance_after":612597,"source":{"system":"sec-edgar","filing":"0001179110-20-008623","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008623/edgar.xml","form_type":"4"}},{"id":3072632,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-31T16:59:36.000Z","date":"2020-07-29","kind":"sale","acquired":false,"shares":1816,"price":26.03,"value":47270.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.35, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4."}],"balance_after":613197,"source":{"system":"sec-edgar","filing":"0001179110-20-008623","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008623/edgar.xml","form_type":"4"}},{"id":3074189,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T16:40:13.000Z","date":"2020-07-28","kind":"sale","acquired":false,"shares":600,"price":35.45,"value":21270.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.11 to $36.00, inclusive."}],"balance_after":615013,"source":{"system":"sec-edgar","filing":"0001179110-20-008539","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008539/edgar.xml","form_type":"4"}},{"id":3074188,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T16:40:13.000Z","date":"2020-07-28","kind":"sale","acquired":false,"shares":1650,"price":33.79,"value":55753.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.65 to $34.34, inclusive."}],"balance_after":615613,"source":{"system":"sec-edgar","filing":"0001179110-20-008539","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008539/edgar.xml","form_type":"4"}},{"id":3074187,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T16:40:13.000Z","date":"2020-07-28","kind":"sale","acquired":false,"shares":1200,"price":33.09,"value":39708.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.60 to $33.34, inclusive."}],"balance_after":617263,"source":{"system":"sec-edgar","filing":"0001179110-20-008539","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008539/edgar.xml","form_type":"4"}},{"id":3074186,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T16:40:13.000Z","date":"2020-07-28","kind":"sale","acquired":false,"shares":3493,"price":31.53,"value":110134.29,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.01 to $32.01, inclusive."}],"balance_after":618463,"source":{"system":"sec-edgar","filing":"0001179110-20-008539","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008539/edgar.xml","form_type":"4"}},{"id":3074185,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T16:40:13.000Z","date":"2020-07-28","kind":"sale","acquired":false,"shares":14243,"price":30.42,"value":433272.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $31.00, inclusive."}],"balance_after":621956,"source":{"system":"sec-edgar","filing":"0001179110-20-008539","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008539/edgar.xml","form_type":"4"}},{"id":3074184,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T16:40:13.000Z","date":"2020-07-28","kind":"sale","acquired":false,"shares":1811,"price":28.63,"value":51848.93,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.50 to $29.41, inclusive."}],"balance_after":636199,"source":{"system":"sec-edgar","filing":"0001179110-20-008539","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008539/edgar.xml","form_type":"4"}},{"id":3074183,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T16:40:13.000Z","date":"2020-07-28","kind":"sale","acquired":false,"shares":2600,"price":26.85,"value":69810.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.38 to $27.38, inclusive."}],"balance_after":638010,"source":{"system":"sec-edgar","filing":"0001179110-20-008539","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008539/edgar.xml","form_type":"4"}},{"id":3074182,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T16:40:13.000Z","date":"2020-07-27","kind":"sale","acquired":false,"shares":338,"price":26.08,"value":8815.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.06 to $26.24, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) to (8) to this Form 4."}],"balance_after":640610,"source":{"system":"sec-edgar","filing":"0001179110-20-008539","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008539/edgar.xml","form_type":"4"}},{"id":3075649,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-27T16:07:22.000Z","date":"2020-07-24","kind":"sale","acquired":false,"shares":300,"price":26,"value":7800.0,"ownership":{"direct":true},"balance_after":640948,"source":{"system":"sec-edgar","filing":"0001179110-20-008490","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008490/edgar.xml","form_type":"4"}},{"id":3075648,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-27T16:07:22.000Z","date":"2020-07-23","kind":"sale","acquired":false,"shares":93,"price":27.29,"value":2537.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.20 to $27.49, inclusive."}],"balance_after":641248,"source":{"system":"sec-edgar","filing":"0001179110-20-008490","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008490/edgar.xml","form_type":"4"}},{"id":3075647,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-27T16:07:22.000Z","date":"2020-07-23","kind":"sale","acquired":false,"shares":1950,"price":26.58,"value":51831.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.11 to $27.10, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":641341,"source":{"system":"sec-edgar","filing":"0001179110-20-008490","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008490/edgar.xml","form_type":"4"}},{"id":3076985,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-23T16:31:27.000Z","date":"2020-07-22","kind":"sale","acquired":false,"shares":75,"price":27.445,"value":2058.375,"ownership":{"direct":true},"balance_after":643291,"source":{"system":"sec-edgar","filing":"0001179110-20-008426","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008426/edgar.xml","form_type":"4"}},{"id":3076984,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-23T16:31:27.000Z","date":"2020-07-22","kind":"sale","acquired":false,"shares":1297,"price":26.69,"value":34616.93,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.30 to $27.20, inclusive."}],"balance_after":643366,"source":{"system":"sec-edgar","filing":"0001179110-20-008426","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008426/edgar.xml","form_type":"4"}},{"id":3076983,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-23T16:31:27.000Z","date":"2020-07-21","kind":"sale","acquired":false,"shares":223,"price":26.56,"value":5922.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.31 and $27.05, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":644663,"source":{"system":"sec-edgar","filing":"0001179110-20-008426","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008426/edgar.xml","form_type":"4"}},{"id":3078809,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T16:44:46.000Z","date":"2020-07-20","kind":"sale","acquired":false,"shares":472,"price":27.68,"value":13064.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.40 to $28.11, inclusive."}],"balance_after":644886,"source":{"system":"sec-edgar","filing":"0001179110-20-008399","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008399/edgar.xml","form_type":"4"}},{"id":3078808,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T16:44:46.000Z","date":"2020-07-20","kind":"sale","acquired":false,"shares":2257,"price":26.7,"value":60261.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.375 to $27.10, inclusive."}],"balance_after":645358,"source":{"system":"sec-edgar","filing":"0001179110-20-008399","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008399/edgar.xml","form_type":"4"}},{"id":3078807,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T16:44:46.000Z","date":"2020-07-17","kind":"sale","acquired":false,"shares":1601,"price":26.66,"value":42682.66,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.87, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4."}],"balance_after":647615,"source":{"system":"sec-edgar","filing":"0001179110-20-008399","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008399/edgar.xml","form_type":"4"}},{"id":3083729,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-14T16:40:56.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":2145,"price":27.13,"value":58193.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.70, inclusive."}],"balance_after":649216,"source":{"system":"sec-edgar","filing":"0001179110-20-008254","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008254/edgar.xml","form_type":"4"}},{"id":3083728,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-14T16:40:56.000Z","date":"2020-07-10","kind":"sale","acquired":false,"shares":2659,"price":27.41,"value":72883.19,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.01 to $28.01, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":651361,"source":{"system":"sec-edgar","filing":"0001179110-20-008254","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000117911020008254/edgar.xml","form_type":"4"}},{"id":3312671,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":146638,"kind":"person","name":"Marshall Randall","position":1,"cik":"0001799325","reported_name":"Marshall Randall","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-13T18:59:30.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":654020,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were received in exchange for 3,428,572 shares of ArTara Sub Common Stock in connection with the Merger."}],"balance_after":654020,"source":{"system":"sec-edgar","filing":"0001209191-20-003225","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799325/000120919120003225/doc4.xml","form_type":"4"}}]}